Clinical trials
Completed Observational Thalassemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 6 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 45 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HaEmek Medical Center, Israel | 8 |
| Carelon Research | 4 |
| University of California, San Francisco | 4 |
| Assiut University | 2 |
| Haikou Affiliated Hospital of Central South University Xiangya School of Medicine | 2 |
| Mahidol University | 2 |
| St. Jude Children's Research Hospital | 2 |
| UCSF Benioff Children's Hospital Oakland | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Bacha Khan Medical College | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thalassemia | 45 |
| Anemia, Sickle Cell | 22 |
| Hemoglobinopathies | 8 |
| Iron Overload | 6 |
| Fanconi Anemia | 4 |
| Hematologic Neoplasms | 4 |
| Immunologic Deficiency Syndromes | 4 |
| Hypertension, Pulmonary | 3 |
| beta-Thalassemia | 3 |
| Anemia, Diamond-Blackfan | 2 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.